I. Hernández-Verdin

Molecular and clinical diversity in primary central nervous system lymphoma.

K. Hoang-Xuan, O. Chinot, K. Mokhtari, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model

M. Sanson, A. Petiet, A. Idbaih, 2023, Pharmaceutics.

Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies

K. Hoang-Xuan, A. Alentorn, Andrea Morales-Martinez, 2022, Current opinion in neurology.

Prognostic factors in primary central nervous system lymphoma

K. Hoang-Xuan, A. Alentorn, C. Houillier, 2022, Current opinion in oncology.

Treating central nervous system lymphoma in the era of precision medicine

K. Hoang-Xuan, A. Alentorn, C. Houillier, 2020 .

Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma

M. Sanson, A. Idbaih, A. Alentorn, 2022, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

CD80 and CD86: expression and prognostic value in newly diagnosed glioblastoma

M. Sanson, A. Idbaih, A. Alentorn, 2021 .

Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin’s Lymphomas from Genome-Wide Association Studies

K. Hoang-Xuan, A. Alentorn, K. Mokhtari, 2020, International journal of molecular sciences.